Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

Sale # 159: BioPharma Analytical Equipment: Mass Spectrometers, HPLC Systems, Analyzer, Microscopes, Centrifuges & More! Multiple Locations.

Starting: Jul 22nd, 2026 7:00am PDT

Ending: Jul 23rd, 2026 9:00am PDT

Immediately Accepting Bids

Past Auctions

Sale #2: Online Auction Featuring Pharmaceutical Packaging Equipment Surplus To Future Needs Of Kindeva! St. Louis, MO.

Starting: Oct 17th, 2024 7:00am CDT

Ending: Oct 18th, 2024 9:00am CDT

Immediately Accepting Bids
Sale #4: Online Auction Featuring Surplus Oral Solid Dose Equipment From Catalent! Winchester, KY.

Starting: Oct 15th, 2024 7:00am EDT

Ending: Oct 16th, 2024 11:00am EDT

Immediately Accepting Bids
Online Auction Featuring Quality Biotech and Pharmaceutical Lab Equipment From Multiple Global Sellers! Multiple Locations, US.

Starting: Oct 10th, 2024 7:00am PDT

Ending: Oct 11th, 2024 8:00am PDT

Immediately Accepting Bids
The 138th Sale Featuring State Of The Art Biopharma R&D Lab Equipment From The World’s Premier Pharmaceutical Manufacturer!

Starting: Oct 2nd, 2024 7:00am PDT

Ending: Oct 3rd, 2024 9:00am PDT

Immediately Accepting Bids
Sale #2 Major Online Auction Featuring Pharmaceutical Manufacturing, Chromatography, & Lab Equipment from Emergent BioSolutions! Baltimore, MD.

Starting: Sep 24th, 2024 7:00am EDT

Ending: Sep 25th, 2024 12:00pm EDT

Immediately Accepting Bids
Online Auction Featuring Quality Biotech and Pharmaceutical Lab Equipment From Multiple Global Sellers! Multiple Locations, US.

Starting: Sep 19th, 2024 7:00am PDT

Ending: Sep 20th, 2024 8:00am PDT

Immediately Accepting Bids
Online Auction Featuring Lab Equipment From An Innovative Drug Delivery Systems Company! Sandy Springs, GA.

Starting: Sep 16th, 2024 7:00am EDT

Ending: Sep 17th, 2024 11:00am EDT

Immediately Accepting Bids
Online Auction Featuring Late Model Biotech and Pharmaceutical Lab Assets Surplus to Hookipa Pharma! Vienna, Austria.

Starting: Aug 15th, 2024 7:00am CEST

Ending: Aug 21st, 2024 11:00am CEST

Immediately Accepting Bids
Online Auction Featuring Late Model Lab and Process Equipment No Longer Required By Triton Algae Innovations! San Diego, CA.

Starting: Aug 7th, 2024 7:00am PDT

Ending: Aug 8th, 2024 9:00am PDT

Immediately Accepting Bids
Online Auction Featuring Quality BioPharma Lab Equipment From a Leading Rockville, MD Based Therapeutics Company! Rockville, MD.

Starting: Aug 5th, 2024 7:00am EDT

Ending: Aug 6th, 2024 12:00pm EDT

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.